Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
12.46 EUR | +1.63% | +0.65% | +26.88% |
05-20 | BTIG Initiates Abivax at Buy Rating With $43 Price Target | MT |
05-08 | Abivax: four abstracts to be presented on obefazimod | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.88% | 839M | |
+51.84% | 55.7B | |
+40.71% | 39.91B | |
-5.95% | 39.57B | |
-5.56% | 28.16B | |
+15.84% | 26.3B | |
-20.23% | 18.94B | |
+31.89% | 12.17B | |
+26.33% | 12.12B | |
+1.28% | 12.12B |
- Stock Market
- Equities
- ABVX Stock
- News Abivax
- Abivax's Liver Cancer Combo Shows Signs Of Clinical Benefit In Early-Stage Study